ABSTRACT
Short-chain fatty acid (SCFA) biosynthesis is pertinent to production of biofuels, industrial compounds, and pharmaceuticals from renewable resources. To expand on
Escherichia coli
SCFA products, we previously implemented a coenzyme A (CoA)-dependent pathway that condenses acetyl-CoA to a diverse group of short-chain fatty acyl-CoAs. To increase product titers and reduce premature pathway termination products, we conducted
in vivo
and
in vitro
analyses to understand and improve the specificity of the acyl-CoA thioesterase enzyme, which releases fatty acids from CoA. A total of 62 putative bacterial thioesterases, including 23 from the cow rumen microbiome, were inserted into a pathway that condenses acetyl-CoA to an acyl-CoA molecule derived from exogenously provided propionic or isobutyric acid. Functional screening revealed thioesterases that increase production of saturated (valerate), unsaturated (
trans
-2-pentenoate), and branched (4-methylvalerate) SCFAs compared to overexpression of
E. coli
thioesterase
tesB
or native expression of endogenous thioesterases. To determine if altered thioesterase acyl-CoA substrate specificity caused the increase in product titers, six of the most promising enzymes were analyzed
in vitro
. Biochemical assays revealed that the most productive thioesterases rely on promiscuous activity but have greater specificity for product-associated acyl-CoAs than for precursor acyl-CoAs. In this study, we introduce novel thioesterases with improved specificity for saturated, branched, and unsaturated short-chain acyl-CoAs, thereby expanding the diversity of potential fatty acid products while increasing titers of current products. The growing uncertainty associated with protein database annotations denotes this study as a model for isolating functional biochemical pathway enzymes in situations where experimental evidence of enzyme function is absent.
摘要
短链
脂肪酸(SCFA)的
生物合成与利用可再生资源生产
生物燃料、工业化合物和药物有关。为了扩展
大肠杆菌
SCFA 产品,我们先前采用了一种依赖
辅酶 A(CoA)的途径,该途径可将乙酰-CoA 缩合为多种短链脂肪酰-CoAs。为了提高产物滴度并减少过早的途径终止产物,我们进行了
体内
和
体外
分析,以了解并改进从 CoA 中释放
脂肪酸的酰基-CoA
硫代
酯酶的特异性。总共有 62 种推测的细菌
硫酯酶(包括 23 种来自牛瘤胃微
生物组的细菌
硫酯酶)被插入到将乙酰-CoA 缩合成酰基-CoA 分子的途径中,该酰基-CoA 分子来自外源提供的
丙酸或
异丁酸。功能筛选结果显示,
硫酯酶可增加饱和(
戊酸)、不饱和(反式)和乙酰-CoA 分子的产生。
反式
-
2-戊烯酸)和支链(
4-甲基戊酸)SCFAs 的产生。
大肠杆菌
硫酯酶
tesB
或内源性
硫酯酶的原生表达相比。为了确定
硫酯酶酰基-CoA 底物特异性的改变是否会导致产物滴度的增加,对六种最有前景的酶进行了分析
体外
.生化测定显示,产量最高的
硫酯酶依赖于杂合活性,但对产物相关酰基-CoAs 的特异性比对前体酰基-CoAs 的特异性更高。在本研究中,我们引入了新型
硫酯酶,它对饱和、支链和不饱和短链酰基-CoAs 的特异性更强,从而扩大了潜在
脂肪酸产物的多样性,同时提高了现有产物的滴度。由于蛋白质数据库注释的不确定性越来越大,因此本研究可作为在缺乏酶功能实验证据的情况下分离功能性生化途径酶的一种模式。